Paul Matteis Stifel Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
46%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
66.7%
Neutral
33.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Care Facilities
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $28 |
66%
upside
| 1 | +22% |
0
%
| 21 Nov ‘25 12 days ago |
|
|
|
Hold
Maintained
| $3 |
39%
upside
| 1 | – |
–
| 17 Nov ‘25 16 days ago |
|
|
|
Hold
Downgraded
| $61 |
14%
upside
| 2 | +0.25% |
0
%
| 6 Nov ‘25 27 days ago |
|
|
|
Buy
Upgraded
| $202 |
11%
upside
| 1 | +19% |
0
%
| 6 Nov ‘25 27 days ago |
|
|
|
Hold
Maintained
| $445 |
2%
downside
| 1 | – |
–
| 4 Nov ‘25 29 days ago |
|
|
|
Buy
Maintained
| $183 |
20%
upside
| 1 | +6% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $495 |
4%
upside
| 1 | +37% |
0
%
| 6 Oct ‘25 1 month ago |
|
|
|
Hold
Maintained
| $67 |
19%
downside
| 1 | – |
–
| 6 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $27 |
43%
upside
| 1 | +25% |
0
%
| 6 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $12 |
125%
upside
| 1 | +102% |
0
%
| 25 Sep ‘25 2 months ago |
|
|
|
Buy
Maintained
| $65 |
155%
upside
| 1 | +38% |
0
%
| 24 Sep ‘25 2 months ago |
|